Elevance Health Inc (ELV · NYSE)

ELV · MARKET VIEW

Market view · as of Jun 15, 2026

Revenue (TTM)
$200.42B
+2.6% YoY
Gross margin
25.9%
EPS (latest q)
$12.58
vs $10.81 est · beat
52-wk position
87.9%
-4.4% vs 52w high · +2.3% 1mo

Price (last ~year)

Elevance Health (ELV) reported Q1 2026 revenue of $50.18 billion and net income of $1.76 billion, having beaten analyst earnings estimates in three of the last four quarters. Despite a 16.8% year-over-year decline in earnings, the stock has gained 37.6% over the last three months to close at $404.07. The company maintains a market capitalization of $87.75 billion, with $9.66 billion in cash against $31.84 billion in total debt.

Valuation

Market cap
$87.75B
P/E
17.12
PEG
1.479
P/B
1.999
P/S
0.438
Beta
0.682
Analyst target
$415.81

Quality & returns

Gross margin
25.9%
Operating margin
5.3%
Profit margin
2.6%
ROE
12.1%
ROA
4.0%

Price movement

Last
$404.07
1-month
+2.3%
3-month
+37.6%
RSI (14)
56
vs SMA200
+20.2%
52-wk position
87.9% -4.4% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$50.18B$2.66B$1.76B$2.77B
2025-12-31$49.75B$581.0M$547.0M$987.0M
2025-09-30$50.71B$1.76B$1.19B$2.14B
2025-06-30$49.78B$2.63B$1.74B$3.01B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots